Awad Mark M, Calkins Hugh, Judge Daniel P
Johns Hopkins University School of Medicine and Johns Hopkins University Cellular and Molecular Medicine Program, Baltimore, MD, USA.
Nat Clin Pract Cardiovasc Med. 2008 May;5(5):258-67. doi: 10.1038/ncpcardio1182. Epub 2008 Apr 1.
Arrhythmogenic right ventricular dysplasia/cardiomyopathy is an inherited cardiomyopathy estimated to affect approximately 1 in 5,000 individuals. Cardinal manifestations include right ventricular enlargement and dysfunction, fibrofatty replacement of myocytes in the right ventricle, characteristic electrocardiographic abnormalities, and ventricular arrhythmia most commonly arising from the right ventricle. The disease is frequently familial and typically involves autosomal dominant transmission with low penetrance and variable expressivity. Approximately 50% of symptomatic individuals harbor a mutation in one of the five major components of the cardiac desmosome. Nevertheless, other genetic modifiers and environmental factors complicate the clinical management of mutation carriers as well as counseling of their relatives. This Review summarizes the known genetic mutations associated with arrhythmogenic right ventricular dysplasia/cardiomyopathy, describes possible origins of recurrent mutations, presents theories on the pathogenesis of disease following a mutation, and discusses the current issues surrounding clinical use of genetic analysis in the assessment of individuals with this condition.
致心律失常性右室发育不良/心肌病是一种遗传性心肌病,估计每5000人中约有1人受其影响。主要表现包括右心室扩大和功能障碍、右心室心肌细胞的纤维脂肪替代、特征性心电图异常以及最常见于右心室的室性心律失常。该疾病常具有家族性,通常呈常染色体显性遗传,具有低外显率和可变表达性。约50%有症状的个体在心脏桥粒的五个主要成分之一中存在突变。然而,其他基因修饰因子和环境因素使突变携带者的临床管理及其亲属的遗传咨询变得复杂。本综述总结了与致心律失常性右室发育不良/心肌病相关的已知基因突变,描述了复发性突变的可能起源,提出了突变后疾病发病机制的理论,并讨论了围绕基因分析在评估患有这种疾病的个体时临床应用的当前问题。